Earlier this month, Omeros Corporation announced that the FDA approved YARTEMLEA (narsoplimab-wuug), the first and only therapy for hematopoietic stem cell transplant-associated thrombotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback